We had observed that several patients with acute promyelodiagnosis had the t(15;17). Molecular testing for the t(15;17) cytic leukemia (APL) were markedly obese. Therefore we was only begun in 1991. Since then six of the seven patients determined the relationship between obesity and a diagnosis with APL without the t(15;17) on conventional cytogenetic of APL among patients with acute myelocytic leukemia (AML).
The Wilcoxon Mann-Whitney test was used to compare the distributions of numerical-valued variables between patients with APL and patients with other types of AML. Association Introduction between qualitative variables was assessed by the generalized Fisher exact test. Effects of covariates on the probability an Acute promyelocytic leukemia (APL) is distinguished from AML patient had APL were evaluated by logistic regression. other types of acute myeloid leukemia (AML) by the presence All computations were carried out on a DEC Alpha Server of a PML-RAR fusion protein formed consequent to a t(15;17), 2100 5/250 running OSF/1. a hemorrhagic diathesis, and a unique responsiveness to alltrans retinoic acid and anthracyclines.
1 Recently, Douer et al 2 reported a higher than expected incidence of APL among LatResults inos with AML, both at Los Angeles County-University of Southern California Medical Center and in separate cases Table 1 and Figure 1 illustrate the relationship between BMI identified by the Los Angeles County Cancer Surveillance Proand diagnosis of APL among patients with AML. The associgram. Over the last 15 years at MD Anderson we have noted ation between BMI and APL was the same when attention was that several patients with APL were markedly obese, often in restricted to those APL patients documented to have the excess of 300 pounds. Douer et al's report prompted us to t(15;17) on conventional cytogenetic analysis (P = 0.0003). examine formally the relationship between APL, body mass index (BMI), ethnicity, and age in patients with newly diagnosed AML. Histograms indicating number of cases of APL (top) and other types of AML (bottom) with indicated values for BMI.
Table 3B
Logistic regression model predicting APL among AML patients excluding the five of 120 APL patients with BMI Ͼ50
Like Douer et al, 2 we found a strong tendency for Latino patients with AML to have APL ( patients (22) prevents a firm conclusion (Table 2) . Finally, an
analysis analogous to that illustrated in Table 1 for Orientals, Whites, Latinos and Blacks, respectively. Simi-= BMI, age and (Latino) are as noted in Table 3A .
larly, age and ethnic origin were interrelated (P Ͻ 10
Kruskal-Wallis test) with Latinos and Orientals on average 10 years younger than Whites and Blacks (mean ages 43.9, 42.9, weighed 316, 369, 400, 418 and 480 pounds. The first of 52.8 and 51.1 years for these four groups, respectively). BMI these five was a 37-year-old white woman, the second a 23-and age were not related.
year-old Latino woman, the third a 40-year-old white woman, Logistic regression was used to sort out these interrelationthe fourth a 40-year-old white man and the fifth a 28-yearships and determine which factors were predictive of APL old Latino man. Omitting these five patients from the analysis among patients with AML. The final logistic model (Table 3A) did not alter the conclusion that increasing BMI is an indicates that BMI, age and Latino (as opposed to White, independent predictor of development of APL (Table 3B ) Black or Oriental) origin were all independent predictors of APL. This can also be appreciated by examining the contour plots of Figure 2a and b which show the estimated probability Discussion of APL according to BMI and age in both Latinos and nonlatinos.
While confirmatory of Douer et al's 2 report of an increased As can be seen in Figure 1 , five of our 120 patients with incidence of APL in Latinos with AML, our report is, we APL had BMI Ͼ50 (vs none of the 1125 patients with other believe, the first to note an association between increasing types of AML). These five (three males and two females) BMI and APL. The mean BMI in our 1125 non-APL patients was 25.08 with a standard deviation of 5.28 vs 27.65 and Table 2 Relationship between 'ethnicity' and APL 7.79, respectively, in our APL patients. While these means do not appear to differ greatly, the apparently small difference in
Ethnic group
Patients APL (%) 95% CI for % BMI across the two samples of APL and non-APL patients has APL a profound effect on the probability of APL (P Ͻ 10 −4 below), it appears that APL patients are 'heavy' and not that patients with other types of AML are 'thin' or 'cachectic'. Such
, Fisher exact test for hypothesis of no difference between percent of patients with APL in the different ethnic groups.
cachexia could in theory develop during a pre-leukemic Nonetheless, assuming that BMI is normally distributed with a mean of 25.3 and standard deviation of 4.0 for US males ages 18-74, 12 the probability of a male with a BMI у50 is Ͻ0.0001. Hence, the probability that three out of our 60 males with APL would have a BMI у50 is virtually nil under the null hypothesis that our male APL population and the general male population do not differ in BMI. Similar considerations apply to the female population (mean BMI 25.0, standard deviation 5.6 for US females ages 18-74).
12 Hence our data suggest a relationship between APL and obesity.
Although our data indicate an association between increasing BMI and a diagnosis of APL, at least among AML patients, the explanation for the association is obscure. We considered two explanations for the phenomenon we discovered although both were purely speculative and none appeared satisfactory. First, was the possibility that adipose tissue sequesters endogenous retinoids. Such sequestration could prevent functional activation of PML-RAR fusion protein and, consequentially, differentiation of promyelocytes. 13 This hypothesis presupposes that not all people with this fusion protein develop APL; only those with inadequate concentrations of retinoids in promyelocytes do so. In addition to the conceptual difficulty with this formulation, it is known that although adipocytes are important sites of synthesis of retinol-binding protein and although adipose tissue accounts for a substantial proportion of total body endogenous retinoid, retinoids in adipose tissue are in dynamic equilibrium with retinoids in other with percentage of body fat (although concentrations do vary at any single percent), 15 it has been proposed that obesity is associated with leptin resistance resulting from a disordered phase of the illness, such phases being more common in patients with other types of AML than in patients with APL. It leptin receptor. The human gene coding for this receptor has now been localized to chromosome 1p. 16 It is of interest that remains to be seen if the association between increasing BMI and a diagnosis of APL among patients with AML will be limthe leptin receptor has recently been shown to have a nearly identical ligand binding domain as a sequence (B219) that is ited to patients presenting to us. An international metaanalytic study would be useful in confirming our results. It expressed in enriched hematopoietic stem cells. 17 It is tempting to speculate that abnormalities in B219 play a role in was interesting that 20.5% of Orientals with AML had APL; although the 95% confidence interval for this rate was wide, development of both obesity and APL although it is unclear how the t(15;17) would fit into this formulation. it barely overlapped the 95% confidence interval for the proportion of white AML patients who had APL (Table 2) . However, the number of Oriental AML patients was insufficient to see if 'Oriental' was a predictor of APL in patients with AML. Acknowledgments In two large studies of the Japan Acute Leukemia Study Group (JALSG) the incidence of APL was 20 and 18% among 326
We thank Soon Woo for her expert assistance in preparing the and 252 patients, respectively, with AML. 6, 7 This compares manuscript. We have also benefitted from discussions of the with an incidence of 10% in our 1245 AML patients. The manuscript with Drs Scott Lipmann and Waun Ki Hong at MD median age of the patients in the two JALSG studies was 48
Anderson, Peter Davis at the University of Texas Medical years, while the median age in our 1245 patients was 54
School in Houston, William Blaner at Columbia University, years. The younger age of the Japanese patients may account New York and Jules Hirsch at Rockefeller University, New for the higher proportion of APL cases, since APL patients in York. Japan, as at MD Anderson, appear younger than patients with other types of AML. 8 It should be pointed out that most of our Oriental patients were not of Japanese background. A metaReferences analysis would again be useful to investigate the incidence of has been reported by others. [9] [10] [11] 2 Douer D, Preston-Martin S, Chang E, Nichols PW, Watkins KJ, As did Douer et al, 2 we restricted attention to patients with obesity and development of APL in the general population.
